Sara Hamon

78 papers receiving 3.8k citations

Sara Hamon's Hit Papers

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial 2022 · 181 citations
1810+3+6Years since publication200400600

Peers

Sara Hamon
Comparison fields: 5 of 116
  • Ophthalmology 608
  • Cardiology and Cardiovascular Medicine 772
  • Endocrinology, Diabetes and Metabolism 451
  • Cancer Research 281
  • Hepatology 133
Replace Satoshi Tanaka with:
Satoshi Tanaka Japan
Lan Jiang United States
Lennart C. Karssen Netherlands
Luo‐Ping Ger Taiwan
Cathy S.J. Fann Taiwan
Graham Heap United Kingdom
Jianfeng Xu United States
Xiaohong Jin China
Katharina Schramm Germany
Christian Schulz Germany
Sara Hamon relative to Satoshi Tanaka Japan Satoshi Tanaka's profile →
Citations per field
00.5×2×4×6×8.9×
Satoshi Tanaka · 1×
Citations per year

Countries citing papers authored by Sara Hamon

Since Specialization
Citations

This map shows the geographic impact of Sara Hamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Hamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Hamon more than expected).

Fields of papers citing papers by Sara Hamon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Hamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Hamon. The network helps show where Sara Hamon may publish in the future.

Co-authors

The 25 scholars most cited alongside Sara Hamon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sara Hamon Line = papers co-authored together Sara Hamon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
Hit paper breakdown →
2017704
2 2019200
3 2008193
4
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Hit paper breakdown →
2022181
5 2020173
6 2021157
7 2008152
8 2008150
9 2008110
10 201598
11 201196
12 200895
13 201292
14 200385
15 200779
16 201073
17 201070
18 200766
19 200656
20 201453

About Sara Hamon

Sara Hamon is a scholar working on Cellular and Molecular Neuroscience, Ophthalmology, Pharmacology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 79 papers that have together received 4.0k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (11 papers), Lipoproteins and Cardiovascular Health (9 papers), Cannabis and Cannabinoid Research (8 papers), Retinal Diseases and Treatments (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipid metabolism and disorders (4 papers), Genetic Associations and Epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Ophthalmology (608 citations), Cardiology and Cardiovascular Medicine (772 citations), Endocrinology, Diabetes and Metabolism (451 citations), Cancer Research (281 citations) and Hepatology (133 citations). Sara Hamon has collaborated with scholars based in United States, China and France. Frequent co-authors include Jürg Ott, David A. Nielsen, Peter J. Francis, Mary Jeanne Kreek, Michael Lawrence Klein, Thomas R. Kosten, Poulabi Banerjee, Richard G. Weleber, Ann Ho and Dennis W. Schultz. Their work appears in journals such as Pharmacogenetics and Genomics, The Journal of Infectious Diseases, Psychiatric Genetics, Journal of Lipid Research and Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact